Obstructive lung diseases such as COPD and asthma are often treated ... With extrinsic restrictive lung disease, treatment of ...

There is a misconception that experiencing constant breathlessness is a typical part of getting older when this is not the ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

Although no cause of death or further details were given, the news comes months after Lynch announced he had been living with ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

COPD health risks: Chronic obstructive pulmonary disease (COPD) is a serious health condition that affects the lungs, and also poses a risk to a person's overall well-being. This disease raises ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

Conclusion. In the treatment of COPD exacerbations, systemic corticosteroids improve airflow limitations, decrease treatment failure rates, decrease the risk of relapse, and may improve symptoms ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.